Canada · Delayed Price · Currency is CAD Decibel Cannabis Company Earnings Call Transcripts
Fiscal Year 2026
-
A leading ready-to-consume cannabis producer, the company is expanding internationally with strong growth in Germany and other markets, leveraging Canadian expertise and in-house genetics. Financials show consistent profitability, robust margins, and reaffirmed double-digit growth guidance for 2024.
-
Q1 2026 delivered 41% revenue growth, record international sales, and doubled adjusted EBITDA, with strong domestic market share gains and a 51% gross margin. Guidance for 2026 and Q2 remains robust, supported by improved international permit timelines and disciplined capital allocation.
Fiscal Year 2025
-
Revenue grew 22% to CAD 113 million, driven by nearly 5x international sales and strong domestic brands. 2026 guidance calls for 18% revenue and 26% EBITDA growth, with continued international expansion and margin improvements expected.
-
A leading Canadian cannabis company is leveraging its strong domestic platform and regulatory expertise to drive rapid international expansion, particularly in Europe and Australia. With robust financial performance, scalable operations, and a focus on value-added products, it expects continued growth and profitability.